We discuss the opportunity as biotech stocks trade at record low valuations, despite strong prospects for the sector...
Chairman of International Biotechnology Trust, John Aston, explains how his unusual background in both biotechnology and banking come together on the trust...
A well-resourced biotechnology fund that has produced annualised returns of +18% under the current manager, offering a yield of 4%...
We scour the investment trust universe for trusts offering chunky yields on a discount...
Searching for the Tesla of tomorrow…
As equity valuations continue to defy logic, we identify the trusts least correlated to their fortunes...
Proven alpha generation from a strong management team, low correlation to mainstream equities, and a yield of 4%...